Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stoke Therapeutics (STOK) Profit After Tax: 2022-2024

Historic Profit After Tax for Stoke Therapeutics (STOK) over the last 3 years, with Dec 2024 value amounting to -$89.0 million.

  • Stoke Therapeutics' Profit After Tax fell 45.09% to -$38.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.6 million, marking a year-over-year increase of 138.47%. This contributed to the annual value of -$89.0 million for FY2024, which is 15.01% up from last year.
  • Stoke Therapeutics' Profit After Tax amounted to -$89.0 million in FY2024, which was up 15.01% from -$104.7 million recorded in FY2023.
  • In the past 5 years, Stoke Therapeutics' Profit After Tax ranged from a high of -$89.0 million in FY2024 and a low of -$104.7 million during FY2023.
  • For the 3-year period, Stoke Therapeutics' Profit After Tax averaged around -$98.2 million, with its median value being -$101.1 million (2022).
  • As far as peak fluctuations go, Stoke Therapeutics' Profit After Tax dropped by 3.59% in 2023, and later climbed by 15.01% in 2024.
  • Over the past 3 years, Stoke Therapeutics' Profit After Tax (Yearly) stood at -$101.1 million in 2022, then fell by 3.59% to -$104.7 million in 2023, then increased by 15.01% to -$89.0 million in 2024.